Tropical Medicine and Infectious Disease (Aug 2023)

Parasite Detection in Visceral Leishmaniasis Samples by Dye-Based qPCR Using New Gene Targets of <i>Leishmania infantum</i> and <i>Crithidia</i>

  • Nayore Tamie Takamiya,
  • Luana Aparecida Rogerio,
  • Caroline Torres,
  • João Augusto Franco Leonel,
  • Geovanna Vioti,
  • Tricia Maria Ferreira de Sousa Oliveira,
  • Karoline Camila Valeriano,
  • Gabriane Nascimento Porcino,
  • Isabel Kinney Ferreira de Miranda Santos,
  • Carlos H. N. Costa,
  • Dorcas Lamounier Costa,
  • Tauana Sousa Ferreira,
  • Rodrigo Gurgel-Gonçalves,
  • João Santana da Silva,
  • Felipe Roberti Teixeira,
  • Roque Pacheco De Almeida,
  • José M. C. Ribeiro,
  • Sandra Regina Maruyama

DOI
https://doi.org/10.3390/tropicalmed8080405
Journal volume & issue
Vol. 8, no. 8
p. 405

Abstract

Read online

Visceral leishmaniasis (VL) is a neglected disease considered a serious public health problem, especially in endemic countries. Several studies have discovered monoxenous trypanosomatids (Leptomonas and Crithidia) in patients with VL. In different situations of leishmaniasis, investigations have examined cases of co-infection between Leishmania spp. and Crithidia spp. These coinfections have been observed in a wide range of vertebrate hosts, indicating that they are not rare. Diagnostic techniques require improvements and more robust tools to accurately detect the causative agent of VL. This study aimed to develop a real-time quantitative dye-based PCR (qPCR) assay capable of distinguishing Leishmania infantum from Crithidia-related species and to estimate the parasite load in samples of VL from humans and animals. The primer LinJ31_2420 targets an exclusive phosphatase of L. infantum; the primer Catalase_LVH60-12060_1F targets the catalase gene of Crithidia. Therefore, primers were designed to detect L. infantum and Crithidia sp. LVH60A (a novel trypanosomatid isolated from VL patients in Brazil), in samples related to VL. These primers were considered species-specific, based on sequence analysis using genome data retrieved from the TriTryp database and the genome assembling of Crithidia sp. LVH60A strain, in addition to experimental and clinical data presented herein. This novel qPCR assay was highly accurate in identifying and quantifying L. infantum and Crithidia sp. LVH60A in samples obtained experimentally (in vitro and in vivo) or collected from hosts (humans, dogs, cats, and vectors). Importantly, the screening of 62 cultured isolates from VL patients using these primers surprisingly revealed that 51 parasite cultures were PCR+ for Crithidia sp. In addition, qPCR assays identified the co-infection of L. infantum with Crithidia sp. LVH60A in two new VL cases in Brazil, confirming the suspicion of co-infection in a previously reported case of fatal VL. We believe that the species-specific genes targeted in this study can be helpful for the molecular diagnosis of VL, as well as for elucidating suspected co-infections with monoxenous-like trypanosomatids, which is a neglected fact of a neglected disease.

Keywords